These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23291632)

  • 1. Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2.
    Radziszewska E; Bojanowska E
    Med Sci Monit Basic Res; 2013 Jan; 19():6-11. PubMed ID: 23291632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent pharmacological modification of cannabinoid-1 and glucagon-like peptide-1 receptor activity affects feeding behavior and body weight in rats fed a free-choice, high-carbohydrate diet.
    Radziszewska E; Wolak M; Bojanowska E
    Behav Pharmacol; 2014 Feb; 25(1):53-60. PubMed ID: 24370558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined stimulation of glucagon-like peptide-1 receptor and inhibition of cannabinoid CB1 receptor act synergistically to reduce food intake and body weight in the rat.
    Bojanowska E; Radziszewska E
    J Physiol Pharmacol; 2011 Aug; 62(4):395-402. PubMed ID: 22100840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
    Kanoski SE; Fortin SM; Arnold M; Grill HJ; Hayes MR
    Endocrinology; 2011 Aug; 152(8):3103-12. PubMed ID: 21693680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake.
    Navarro M; Rodriquez de Fonseca F; Alvarez E; Chowen JA; Zueco JA; Gomez R; Eng J; Blázquez E
    J Neurochem; 1996 Nov; 67(5):1982-91. PubMed ID: 8863504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hindbrain leptin and glucagon-like-peptide-1 receptor signaling interact to suppress food intake in an additive manner.
    Zhao S; Kanoski SE; Yan J; Grill HJ; Hayes MR
    Int J Obes (Lond); 2012 Dec; 36(12):1522-8. PubMed ID: 22249232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CB1 receptor agonist, WIN 55,212-2, dose-dependently disrupts object recognition memory in adult rats.
    Baek Jh; Zheng Y; Darlington CL; Smith PF
    Neurosci Lett; 2009 Oct; 464(1):71-3. PubMed ID: 19666083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
    Baggio LL; Huang Q; Brown TJ; Drucker DJ
    Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance on a high-fat diet impairs the anorexic response to glucagon-like-peptide-1 receptor activation.
    Williams DL; Hyvarinen N; Lilly N; Kay K; Dossat A; Parise E; Torregrossa AM
    Physiol Behav; 2011 Jul; 103(5):557-64. PubMed ID: 21515295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55,212-2.
    Pandolfo P; Pamplona FA; Prediger RD; Takahashi RN
    Eur J Pharmacol; 2007 Jun; 563(1-3):141-8. PubMed ID: 17374533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
    Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
    Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of intracerebroventricular or intraperitoneal administration of cannabinoid receptor agonist (WIN 55,212-2) and inverse agonist (AM 251) on the regulation of food intake and hypothalamic serotonin levels.
    Merroun I; Errami M; Hoddah H; Urbano G; Porres JM; Aranda P; Llopis J; López-Jurado M
    Br J Nutr; 2009 May; 101(10):1569-78. PubMed ID: 19245736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
    Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
    Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide.
    Kanoski SE; Rupprecht LE; Fortin SM; De Jonghe BC; Hayes MR
    Neuropharmacology; 2012 Apr; 62(5-6):1916-27. PubMed ID: 22227019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception.
    Hasanein P; Parviz M; Keshavarz M; Javanmardi K
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):439-49. PubMed ID: 17439413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of SR141716 and WIN 55,212-2 on tolerance to ethanol in rats using the acute and rapid procedures.
    Lemos JI; Takahashi RN; Morato GS
    Psychopharmacology (Berl); 2007 Oct; 194(2):139-49. PubMed ID: 17546513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effects of cannabinoid CB1 receptors blockade and cholecystokinin on feeding inhibition.
    Orio L; Crespo I; López-Moreno JA; Reyes-Cabello C; Rodríguez de Fonseca F; Gómez de Heras R
    Pharmacol Biochem Behav; 2011 Apr; 98(2):220-6. PubMed ID: 21163296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
    Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
    Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.
    Järbe TU; LeMay BJ; Olszewska T; Vemuri VK; Wood JT; Makriyannis A
    Pharmacol Biochem Behav; 2008 Nov; 91(1):84-90. PubMed ID: 18640150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A glucagon-like peptide-1 receptor agonist and an antagonist modify macronutrient selection by rats.
    Peters CT; Choi YH; Brubaker PL; Anderson GH
    J Nutr; 2001 Aug; 131(8):2164-70. PubMed ID: 11481412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.